News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
103 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18684)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1160)
Day
1 (214)
2 (187)
3 (160)
4 (138)
5 (74)
7 (52)
8 (139)
9 (151)
10 (114)
11 (132)
12 (58)
14 (27)
15 (145)
16 (92)
17 (98)
18 (106)
19 (70)
21 (14)
22 (92)
23 (109)
24 (105)
25 (106)
26 (50)
28 (28)
29 (103)
30 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
4
5
7
8
9
10
11
12
14
15
16
17
18
19
21
22
23
24
25
26
28
29
30
Ovarian cancer
4 ovarian cancer candidates to watch: GSK, Allarity and more
Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, OSE Immunotherapies and others are advancing their own candidates.
June 29, 2026
·
6 min read
·
Brianna Abbott
Proliant Health & Biologicals Raises the Albumin Standard with AlbufreeDX: Consistent, Animal-Free Recombinant Human Albumin
June 29, 2026
·
2 min read
Press Releases
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
June 29, 2026
·
3 min read
Press Releases
4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia
June 29, 2026
·
4 min read
Press Releases
Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline
June 29, 2026
·
12 min read
Press Releases
Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
June 29, 2026
·
7 min read
Press Releases
Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine
June 29, 2026
·
4 min read
Press Releases
AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
June 29, 2026
·
13 min read
Press Releases
Zelluna ASA activates The Royal Marsden as second clinical site for ZIMA-101, expanding clinical execution capabilities
June 29, 2026
·
2 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - June 29, 2026
June 29, 2026
·
2 min read
1 of 11
Next
